Zoic Capital
Zoic Capital is a venture capital firm established in 2017, located in Bellevue, Washington, with an additional office in Tampa, Florida. The firm specializes in early-stage investments focused on healthcare innovations that lie at the intersection of life sciences and medical technology. Zoic Capital seeks to identify promising scientific advancements that offer broad intellectual property potential and commercial readiness. The firm invests in technologies that support both the development of medical products and the delivery of care. By combining qualitative insights with quantitative analysis, Zoic Capital aims to make informed investment decisions. Additionally, it employs a milestone-based investment approach, crafting unique deal structures tailored to each portfolio company to foster ongoing momentum and success. With a commitment to mentoring, Zoic Capital leverages its expertise and network to help transform research into impactful, market-ready products.
ProbiusDx Inc. is a manufacturer of portable diagnostic devices that utilize an electronic sensing platform to analyze multiple target proteins in real time. This technology allows healthcare professionals to recommend suitable therapies for patients requiring critical care in clinical environments. Founded in 2015 and headquartered in El Cerrito, California, ProbiusDx is focused on enhancing diagnostic capabilities and improving patient outcomes through advanced, accessible diagnostic solutions.
HDT Biotech Corporation, a biotechnology company, develops biotherapeutics for oncology and infectious disease applications. The company focuses on RNA, formulation, and adjuvant technologies. It develops RNA/LION that combines formulation and adjuvant ingredients to stabilize and deliver RNA to the immune system to stimulate responses for therapy or vaccination. The company was founded in 2018 and is based in Seattle, Washington.
BioROSA Technologies Inc. develops a blood test for autism spectrum disorders (ASD). The company offers diagnostic tools to allow clinicians to determine who is at risk for ASD and enables therapeutic developments through blood-based biomarkers and machine learning tools. BioROSA Technologies Inc. was incorporated in 2018 and is based in Belmont, Massachusetts.
ODS Medical Inc. is a Montreal-based medical device company established in 2015, specializing in the design and manufacture of a proprietary Raman spectroscopy system for cancer detection. The company focuses on commercializing this advanced technology to enable real-time detection of tissue abnormalities across various clinical settings. By integrating innovative optical probes with sophisticated software powered by machine learning algorithms, ODS Medical aims to provide physicians with next-generation diagnostic tools. This approach enhances the sensitivity, specificity, and accuracy of medical diagnoses, ultimately empowering healthcare professionals to make critical decisions in real-time.
Juno Diagnostics, Inc. is a health technology company based in San Diego, California, focused on democratizing access to genetic information. Established in 2017, Juno specializes in cell-free DNA-based prenatal testing and is also engaged in the development of genetic testing tools for various applications, including epigenetics, inherited diseases, and cancer diagnostics. The company aims to create simple and cost-effective devices that facilitate point-of-need genetic testing, thereby enhancing accessibility to vital health information.
Optina Diagnostics Inc. is a Canadian company based in Montréal, established in 2010, that focuses on the early detection of Alzheimer’s disease through advanced ocular imaging technology. The company has developed a retinal imaging test that utilizes hyperspectral imaging to identify key biomarkers associated with Alzheimer’s, including beta-amyloid plaques. In addition to Alzheimer’s detection, its imaging systems also aid in diagnosing age-related macular degeneration and ocular diabetic retinopathy. By providing a simple eye exam, Optina's technology enables healthcare professionals to detect and address the underlying causes of memory loss, thereby contributing to improved patient care and outcomes in neurodegenerative diseases.
InnoVein, Inc. is a medical device company based in San Carlos, California, focused on developing innovative solutions for vascular health. Founded in 2015, the company specializes in creating an implantable valve designed to regulate blood flow in the veins, particularly for elderly patients suffering from venous insufficiency. Their technology aims to address the challenges associated with this condition, improving the quality of life for affected individuals. As a venture-backed enterprise, InnoVein is committed to advancing cardiac and arterial health through its specialized medical devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.